| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 07/03/2001 | US6254724 Stabilizing amount of a hindered amine compound selected derivatives of 1-oxyl-2,2,6,6-tetramethyl-piperidin-4-ol or which are their hydroxylamine salts |
| 06/28/2001 | WO2001046263A1 Novel compounds |
| 06/28/2001 | WO2001046200A1 Novel piperidine and piperazine derivatives |
| 06/28/2001 | WO2001046148A1 Novel processes |
| 06/28/2001 | WO2001046147A1 A process for preparing 4-substituted piperidines |
| 06/28/2001 | WO2001046146A1 New modulators of dopamine neurotransmission |
| 06/28/2001 | WO2001046145A1 New modulators of dopamine neurotransmission |
| 06/28/2001 | WO2001046144A1 New modulators of dopamine neurotransmission |
| 06/28/2001 | WO2001046143A1 A process for preparing trans-2,4-disubstituted piperidines |
| 06/28/2001 | WO2001046142A1 A process for the regioselective synthesis of 2,2-dialkyl-4-substituted piperidines |
| 06/28/2001 | WO2001046141A1 Method for the production of n-alkenyl amides |
| 06/28/2001 | WO2001046139A1 Method for producing n-alkenyl amides |
| 06/28/2001 | WO2001045711A1 Urotensin-ii receptor antagonists |
| 06/28/2001 | WO2001045709A1 Substituted piperazine and piperidine calcium channel blockers |
| 06/28/2001 | WO2001045703A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 06/28/2001 | WO2001010834A3 Antibacterial agents |
| 06/28/2001 | WO2000071171A3 Sigma-1 ligands for determining carcinoma proliferative status |
| 06/28/2001 | WO1999063937A9 Multivalent macrolide antibiotics |
| 06/28/2001 | US20010005755 Method of stabilizing N-oxyl compounds in vinyl compounds |
| 06/28/2001 | DE19962936A1 New beta-aminoacid amide derivatives, are integrin antagonists useful for treating inflammatory, autoimmune or immunological disorders e.g. asthma, diabetes or rheumatoid arthritis |
| 06/28/2001 | DE19962405A1 Production of N-alkenyl amides, useful for the production of plastics, comprises liquid phase reaction of an NH-amide with acetylene using a basic alkali metal compound and an alkoxy cocatalyst |
| 06/28/2001 | DE19962138A1 Production of N-alkenyl amides, useful for the production of plastics and paint comprises liquid phase reaction of an NH-amide with acetylene using a basic alkali metal compound and a diol cocatalyst |
| 06/28/2001 | DE19961897A1 Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen Using a film coating as taste coating of pharmaceutical dosage forms |
| 06/28/2001 | CA2394864A1 Novel compounds |
| 06/28/2001 | CA2394095A1 Novel piperidine and piperazine derivatives |
| 06/28/2001 | CA2393724A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 06/27/2001 | EP1110962A1 Process for preparing 1,4-dihydropyridine compounds |
| 06/27/2001 | EP1110556A1 Preventives/remedies for multiple organ failure |
| 06/27/2001 | EP1110544A2 Use of a film coating as taste masking coating for oral dosage forms |
| 06/27/2001 | EP1109786A1 Piperidine derivatives |
| 06/27/2001 | EP1109554A2 Pipecolic acid derivatives for vision and memory disorders |
| 06/27/2001 | EP1109542A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use |
| 06/27/2001 | EP0950048B1 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease |
| 06/27/2001 | EP0733046B1 benzoyl guanidines, their production and their use in medicaments |
| 06/27/2001 | EP0718281B1 Cyclohexanediurea derivative and process for producing the same |
| 06/27/2001 | CN1301265A Novel substituted arylhydroxamic acids as metalloproteinase inhibitors |
| 06/27/2001 | CN1301253A Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists |
| 06/27/2001 | CN1301161A Serotonergic 5HT receptor compounds for treating ocular and CNS disorders |
| 06/27/2001 | CN1300590A Use of coating as taste masking agent for oral preparation |
| 06/27/2001 | CN1067550C Calcium receptor active molecules |
| 06/26/2001 | US6252081 Reducing of the coorresponding quaternary ammonium salt |
| 06/26/2001 | US6252079 Intermediates in the synthesis of camptothecin and related compounds and synthesis thereof |
| 06/26/2001 | US6251949 Oxime derivatives, hydrazone derivatives and use thereof |
| 06/26/2001 | US6251940 Administering to the mammal suffering from a diseases responsive to inhibit monocyte and/or macrophase and/or lymphocyte activation and of lymphocyte proliferation an amide derivative |
| 06/26/2001 | US6251919 Administering aniline derivative for therapy of pain |
| 06/26/2001 | US6251918 For therapy of stroke, cerebral ischemia, head trauma, or epilepsy |
| 06/26/2001 | US6251909 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 06/26/2001 | US6251363 Diagnostic and therapeutic alkylenediamine compounds and process |
| 06/21/2001 | WO2001044226A1 Serine protease inhibitors |
| 06/21/2001 | WO2001044223A1 Inhibitors of interleukin 5 gene expression |
| 06/21/2001 | WO2001044218A1 Quaternary salts of n-substituted cyclic or acyclic amines as pharmaceuticals |
| 06/21/2001 | WO2001044200A2 Selective neurokinin antagonists |
| 06/21/2001 | WO2001044193A1 1,3,4-substituted piperidine analogs and uses thereof in treating addictions |
| 06/21/2001 | WO2001044192A1 Cyclic quaternary ammonium compounds |
| 06/21/2001 | WO2001044191A1 4-aminopiperidine derivatives and their use as medicine |
| 06/21/2001 | WO2001044190A1 Anthracene derivatives as anti-cancer agents |
| 06/21/2001 | WO2001044189A1 Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors |
| 06/21/2001 | WO2001044188A1 Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors |
| 06/21/2001 | WO2001044179A1 Novel succinate compounds, compositions and methods of use and preparation |
| 06/21/2001 | WO2001044178A1 Novel urea compounds, compositions and methods of use and preparation |
| 06/21/2001 | WO2001044167A1 Quaternary ammonium compounds and their use as anti-tussive agents |
| 06/21/2001 | WO2001043744A1 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them |
| 06/21/2001 | WO2001017955A3 Hydroxyacetamidobenzenesulphonamide derivatives |
| 06/21/2001 | WO2000009483A3 Process and intermediates for production of donepezil and related compounds |
| 06/21/2001 | US20010004669 For treatment of depression, anxiety, eating disorders, obesity, drug abuse, cluster headache, migraine, pain and chronic paroxysmal hemicrania and headache associated with vascular disorders |
| 06/21/2001 | CA2395170A1 Anti-cancer agents (iii) |
| 06/21/2001 | CA2395075A1 1,3,4-substituted piperidine analogs and uses thereof in treating addictions |
| 06/21/2001 | CA2393825A1 Novel succinate compounds, compositions and methods of use and preparation |
| 06/21/2001 | CA2393706A1 Cyclic quaternary ammonium compounds |
| 06/21/2001 | CA2393672A1 Selective neurokinin antagonists |
| 06/21/2001 | CA2393027A1 Inhibitors of interleukin 5 gene expression |
| 06/20/2001 | EP1109070A2 1,4-Dihydropyridine charge control agents for electrostatographic toners and developers |
| 06/20/2001 | EP1108710A1 Guaiacoxypropanolamines with alpha/beta-adrenergic blocking activity |
| 06/20/2001 | EP1108053A1 Method for preparing (2r)-piperidine derivatives |
| 06/20/2001 | EP1107953A1 Hydroxamic acid derivatives as proteinase inhibitors |
| 06/20/2001 | EP1107758A2 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase |
| 06/20/2001 | EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 06/20/2001 | EP1107752A1 Pyrrolidine derivatives for vision and memory disorders |
| 06/20/2001 | EP0808303B1 5-(4-subst.-piperidinyl-1)-3-aryl-pentanoic acid derivatives as tachykinin receptor antagonist |
| 06/20/2001 | EP0733043B1 Tricyclic derivatives and their use in pharmaceuticals |
| 06/20/2001 | EP0721452B1 Process for the preparation of sufentanil derivatives by carbene addition/aminolysis of 4-piperidone |
| 06/20/2001 | CN1300281A Compounds with growth hormone releasing properties |
| 06/20/2001 | CN1300280A Process for the preparation of (R)-& alpha, -(2,3-dimethoxyp-henyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
| 06/20/2001 | CN1300278A Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 06/19/2001 | US6248775 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 06/19/2001 | US6248759 Administering a dihydropyridine calcium antagonist |
| 06/19/2001 | US6248756 Inhibitors of farnesyl-protein transferase |
| 06/19/2001 | US6248743 Antithrombotic agents effective to inhibit the production of type 1 plasminogen activator inhibitor (pai-1) |
| 06/19/2001 | US6248304 Piperidine compound |
| 06/14/2001 | WO2001042213A1 Urea compounds having muscarinic receptor antagonist activity |
| 06/14/2001 | WO2001042212A1 Carbamate derivatives having muscarinic receptor antagonist activity |
| 06/14/2001 | WO2001042208A1 Cycloamine ccr5 receptor antagonists |
| 06/14/2001 | WO2001042207A2 Novel methods for the treatment and prevention of ileus |
| 06/14/2001 | WO2001042201A1 N-phenylcarbamates having a microbicide, insecticide and acaricide effect |
| 06/14/2001 | US20010003646 Composition for keeping away vermin |
| 06/14/2001 | CA2393141A1 Novel methods for the treatment and prevention of ileus |
| 06/13/2001 | EP1106614A1 5-Membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/13/2001 | EP1106606A2 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists |
| 06/13/2001 | EP1106605A1 Alpha1b-adrenergic receptor antagonists |
| 06/13/2001 | EP1105132A1 The use of r(+)-g(a)-(2,3-dimethoxyphenyl)-1- 2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of sleep disorders |